Canada Veterinary Healthcare Market | Growth, Trends and Forecast (2018-2023)
Canada Veterinary Healthcare Market - Segmented by Product, Animal, and Geography - Growth, Trends, and Forecast (2018 - 2023)


SEP 2018

Canada Veterinary Healthcare Market - Segmented by Product, Animal, and Geography - Growth, Trends, and Forecast (2018 - 2023)

Purchase Report

The Canada Veterinary Healthcare market is expected to register a CAGR of around 7% during the forecast period, 2018 to 2023. Veterinary medicines are associated with treatment, diagnosis, and prevention of diseases among animals. It covers a variety of animal species, both, in domestic and wild.

Increase in Ownership of Pet Animals

The citizens of Canada prefer ownership of pets, compared to other countries in the similar geographic locations. As per 2014 data published by the Government of Alberta, 57 percent of households, which roughly translates to 7.5 million households in the country, own pets. Furthermore, cats are more popular as pets than dogs. The same source reported that 37 percent of households in the country owned one or more cats, while 32 percent preferred dogs as a pet. During the year 2014, Canadian citizens owned at least 7.9 million cats and 5.9 million dogs. Apart from these animals, birds, fishes, herptiles, and small mammals are also preferred by the Canadian citizens, as roughly 9 percent of the Canadians were reported to own one of these as a pet. The major share of pet animal healthcare is attributed to dogs, as dog owners are more likely to spend on the healthcare needs of their pets. Additionally, a risk of emerging zoonosis, advanced technology leading to innovations and increase awareness about animal health in animal healthcare is also a factor responsible for the growth of veterinary healthcare market.

Increasing Costs of Animal Testing and Veterinary Services

Advances in veterinary care over the past few years have come at high price. For example, according to the North American Pet Insurance Association, a trade group, it is estimated that only a few percentages of the pet population were insured in Canada. So very few pet owners are insured and the remaining pet owner population as to pay the amount from their own pockets. The increasing costs are a major concern and also, many diseases and injuries are diagnosed with an MRI, which used to be inaccessible to all, but the most well-funded university hospitals. That MRI machines are available in many hospitals, vets use this test as standard care for diagnosing and treating cancer, epilepsy, injury, etc., but the test itself also costs over 1000 dollars as this is an incredibly useful and important diagnostic tool, the cost is out of reach for many pet owners who would struggle to be able to afford the surgery and/or treatment following the MRI, let alone the cost of the test itself. Thus, increasing cost of animal testing and veterinary services is hindering the growth of the market.

Also, lack of infrastructure and funding and use of counterfeit medicines are restraining the growth of Canada veterinary healthcare market.

Pressing Need for Cost-Effective Production

Cost-effective production has been extensively used in economic assessments in the field related to animal health. The primary goal of the veterinary vaccines is to increase production of livestock in a cost-effective manner. In Canada, this has been a constraint for the animal healthcare market as achieving significant economies of scale, as a result of the high volume of cases manufactured is difficult. In animal health, cost-benefit analysis has been the preferred tool for economic analysis. There is increasing awareness regarding the need to underpin decisions on resource allocation for animal health, welfare, and production measures with structured and transparent frameworks. In order to provide the best animal health and welfare per unit of resource expended, veterinarians must be able to precisely define a number of specific diseases and the cost of the diseases, the cost of disease control and the threat of a particular disease occurring. Implementing all these practices effectively is a difficult task for any manufacturing company. The complexity involved in achieving cost-effective production is a major challenge for the small and medium establishing firms. The high operational costs also affect this market, which includes sales force, high-energy cost, and low technology. Also, lack of infrastructure and funding, increasing costs of animal testing and veterinary services and use of counterfeit medicines are restraining the growth of veterinary healthcare market

Vaccines are expected to lead the Market

The Vaccines segment in Canada veterinary healthcare market is expected to register a healthy CAGR during the forecasted period due to the presence of good healthcare infrastructure in the country, and it is also experiencing positive trends in the R&D developments.


Key Developments in the Market:

  • June 2018: Elanco Animal Health Introduces New Respiratory PRRS Vaccine a modified-live respiratory vaccine, which is effective in the reduction of porcine reproductive and respiratory syndrome (PRRS), respiratory form, in piglets two weeks or older

Major Players: Bayer Healthcare, Boehringer Ingelheim, Ceva Animal Health, Inc., Elanco (Eli Lilly and Company), Idexx Laboratories, Merck Animal Health, Virbac Corporation, Vitoquinol S.A. and Zoetis Animal Healthcare, amongst others.

Reasons to Purchase this Report

  • Current and future Canada veterinary healthcare market outlook in the developed and emerging markets
  • Analyzing various perspectives of the market with the help of Porter’s five forces analysis
  • The segment that is expected to dominate the market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, market shares, and strategies employed by the major market players
  • 3-month analyst support, along with the market estimate sheet (in Excel)

Customization of the Report

  • This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs

1. Introduction

                1.1 Market Definition

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

                5.1 Current Market Scenario

                5.2 Porters Five Forces

                                5.2.1 Bargaining Power of Suppliers

                                5.2.2 Bargaining Power of Consumers

                                5.2.3 Threat of New Entrants

                                5.2.4 Threat of Substitute Product and Services

                                5.2.5 Competitive Rivalry Within the Industry

6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                6.1 Market Driver

                                6.1.1 Increase in Ownership of Pet Animals

                                6.1.2 Advanced Technology Leading to Innovations in Animal Healthcare

                                6.1.3 Risk of Emerging Zoonosis

                                6.1.4 Increase Awareness About Animal Health

                6.2 Market Restraint

                                6.2.1 Use of Counterfeit Medicines

                                6.2.2 Increasing Costs of Animal Testing And Veterinary Services

                6.3 Opportunities

                6.4 Challenges

7. Market Segmentation

                7.1 By Product Type

                                7.1.1 By Therapeutics




                                       Medical Feed Additives


                                7.1.2 By Diagnostics

                                       Immunodiagnostic Tests

                                       Molecular diagnostics

                                       Diagnostic Imaging

                                       Clinical Chemistry


                7.2 By Animal Type

                                7.2.1 Production animals





                                7.2.2 Companion Animals

                                       Dogs & Cats



8. Company Profile and Competitive Landscape

             8.1 Bayer healthcare

8.2 Boehringer Ingelheim

8.3 Ceva Animal Health Inc.

8.4 Elanco (Eli Lilly and Company)

8.5 Idexx Laboratories

8.6 Merck Animal Health

8.7 Phibro Animal health

8.8 Virbac Corporation

8.9 Vetoquinol SA

8.10 Zoetis Animal healthcare

                **List Not Exhaustive

9. Future of the Market

Purchase Report

Our Clients Include View All

Looking to Customize Report?